Search Results 111-120 of 15568 for Eosinophilia
It is hypothesized that AK002 is more effective than placebo control (alternative hypothesis) in reducing the number of eosinophils per high power field (HPF) ...
About this study. The primary objective of the study is to evaluate the effectiveness of depemokimab 200 mg SC every 26 weeks compared with mepolizumab 300 ...
One hypothesis under current testing is that eosinophils are part of an immune system attack response to certain microbes, including the fungus Alternaria. More ...
Do patients with eosinophilic esophagitis have baseline increased esophageal mucosal impedance? And will treatment that reverses esophageal eosinophilia in ...
We hypothesize a greater peak mast cell density in the esophageal biopsies of children than in adults with EoE. The group (children or adults) which show ...
Learn more about the causes and treatment of eosinophilic esophagitis — a digestive disease caused by an allergic reaction.
... eosinophils, asthma control metrics and quality of life during 12-week treatment in patients with uncontrolled, severe asthma with eosinophilic inflammation.
The purposes of this study are to evaluate the effect of benralizumab on submucosal eosinophils in endobronchial biopsies as measured by major basic protein ( ...
The purposes of this study are to evaluate the effects of Etrasimod on esophageal eosinophilia in adult subjects with active eosinophilic esophagitis (EoE) ...
Clinical Trials · A Study To Investigate Mepolizumab In The Treatment Of Eosinophilic Granulomatosis With Polyangiitis · More about research at Mayo Clinic · Mayo ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.